Article Text

Download PDFPDF
Paediatric screening for hypercholesterolaemia in Europe
  1. D M Kusters1,2,
  2. C de Beaufort3,
  3. K Widhalm4,
  4. O Guardamagna5,
  5. N Bratina6,
  6. L Ose7,
  7. A Wiegman1
  1. 1Department of Pediatrics, Academic Medical Centre, Amsterdam, The Netherlands
  2. 2Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
  3. 3DECCP, Clinique Pediatrique/Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg
  4. 4Division of Clinical Nutrition, Department of Pediatrics, Medical University Vienna, Vienna, Austria
  5. 5Department of Pediatrics, Turin University, Turin, Italy
  6. 6Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, University Medical Centre, Ljubljana, Slovenia
  7. 7Lipid Clinic, Oslo University Hospital Rikshospitalet, Oslo, Norway
  1. Correspondence to Albert Wiegman, Department of Pediatrics, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; a.wiegman{at}


Different screening strategies are currently recommended to identify children with (familial) hypercholesterolaemia in order to initiate early lipid management. However, these strategies are characterised to date by low adherence by the medical community and limited compliance by parents and children. In a literature review, the authors assess which children should undergo screening and which children are in effect identified through the currently recommended strategies. Furthermore, the authors discuss the different screening tools and strategies currently used in Europe and what is known about the negative aspects of screening. The authors conclude that currently recommended selective screening strategies, which are mainly based on family history, lack precision and that a large percentage of affected children who are at increased risk of future coronary artery disease are not being identified. The authors propose universal screening of children between 1 and 9 years of age, a strategy likely to be most effective in terms of sensitivity and specificity for the identification of children with familial hypercholesterolaemia. However, this concept has yet to be proven in clinical practice.

Statistics from


  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.